Bayer Aktiengesellschaft (BAYZF)
OTCMKTS · Delayed Price · Currency is USD
54.80
-0.07 (-0.13%)
At close: Jan 28, 2026
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $52.98 billion as of January 29, 2026. Its market cap has increased by 152.57% in one year.
Market Cap
52.98B
Enterprise Value
91.78B
Revenue
53.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
$54.80
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 52.98B, an increase of 804.08%. That is a compound annual growth rate of 6.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 52.98B | 23.87% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 833.06M |
| Glass House Brands | 797.56M |
| Elite Pharmaceuticals | 486.60M |
| Northwest Biotherapeutics | 463.33M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 361.55M |
| CytoDyn | 320.10M |
| Tian'an Technology Group | 318.63M |